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Open Access
PROGRESS IN PREVENTIVE MEDICINE
We are currently facing a chronic disease crisis around the world, 
which has largely been brought about by preventable risk factors. 
Specifically, physical inactivity, poor nutrition, psychological stress, 
and excess body mass, the risk factors most intricately linked to 
chronic disease, are alarmingly high and on the rise. [1–4] Moreover, 
these unhealthy trends have spread and are increasing in low- to 
middle-income countries. [5,6] In parallel, over centuries, healthcare 
in many countries has evolved into a “reactive” system, one that 
fully engages when symptoms or disease first appears, ignoring 
years of disease trajectory and subclinical risk. Seemingly, we 
have become efficient in prolonging the lifespan through tradi-
tional healthcare and managing chronic disease once it has been 
diagnosed. However, at the same time, this healthcare-mediated 
increase in lifespan is doing so at the sacrifice of the healthspan 
(ie, the number of years a person is healthy and free of disease). [7,8]
There is now broad recognition that preventing unhealthy lifestyle and 
associated physiologic characteristics from ever occurring is the global 
way forward to prevent and reduce the burden of chronic disease. In fact, 
there is clear evidence that the vast majority of chronic diseases can be 
prevented or delayed to a significantly later time in the lifespan by appro-
priate interventions. [9–11] Essentially, in order to increase the healthspan, 
we must transform from a reactionary system to one that is preventive 
at the earliest point possible, promoting health and wellness across the 
lifespan. This transformation requires a recondisderation of what actu-
ally constitutes a healthcare system (and not a “disease care system”). We 
need to rethink the traditional model of a hospital and outpatient clinics. 
Prevention of chronic diseases largely takes place outside of hospitals 
and outpatient clinics. To promote lifelong wellness, prevent chronic dis-
ease risk, and prolong the healthspan, a number of other settings must 
become part of the future healthcare enterprise. The future healthcare 
provider must meet people where they live, go to school, and work. [12,13]
There is also a strong economic rationale for healthcare to 
focus on prolonging the healthspan as the costs of treating 
those who lead an unhealthy lifestyle and develop high chronic 
disease risk or, most commonly, ultimately have one or more 
confirmed chronic disease diagnoses, are much more costly to 
care for through hospitalizations, surgeries, and pharmacother-
apy. Regardless of the economic model that covers healthcare 
in a given country (i.e., government vs private funded or a mix 
thereof ), reduced amounts of a country’s economy devoted to 
the management of chronic disease are highly desirable. [14–18]
The theoretical, technological, and conceptual advances 
throughout the last decade also warrant the rapid transition to a 
“proactive” healthcare system, focused on optimally prolonging 
the healthspan as opposed to managing disease. [7,8,12] The care 
delivered in this proactive system must transform and become 
Preventive, Predictive, Personalized, and Participatory, a concept 
known as “P4 medicine.” [19,20] P4 medicine holds great promise to 
(1) provide deep insights into disease mechanisms; (2) make blood 
a diagnostic window for viewing health and disease for the indi-
vidual; (3) stratify complex diseases into their distinct subtypes 
for an impedance match against proper drugs; (4) provide new 
approaches to drug target discovery; and (5) generate metrics 
for assessing wellness. Patients and consumers will be a major 
driver in the realization of P4 medicine through their participation 
in medically oriented services directed at improving their own 
healthcare. [21–24]
Healthcare education and practice, across the disciplines, com-
monly follows a reductionist approach with strong focus on sin-
gle organs and organ-focused specialties. Complex interactions, 
nonlinearity, and convex responses have been neglected in the 
science and clinical practice of medicine. Convexity in medicine is 
at 2 levels. First is the understanding the effect of dosing and its 
nonlinearity. Second, at the level of risk analysis for patient inter-
ventions. The human body is arguably the most complex system 
known to mankind; we only understand a fraction of its function-
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ality and interactions. A grand challenge impeding optimal pre-
vention and treatment of chronic diseases, such as cancer, arises 
from the complex nature of the disease: the cellular heterogeneity 
and the myriad of dysfunctional molecular and genetic networks 
as results of genetic (somatic) and environmental perturbations. 
Systems biology, with its holistic approach to understanding 
 fundamental principles in biology and the empowering technol-
ogies in genomics, proteomics, single-cell analysis, microfluidics, 
and computational strategies, enables a comprehensive approach 
to medicine, which strives to unveil the pathogenic mechanisms 
of diseases, identify disease biomarkers, and begin thinking about 
new strategies for drug target discovery. Embracing complex sys-
tem expertise and technology will help to improve health and 
advance medicine. Systems biology and the digital revolution are 
together transforming healthcare to a form of systems medicine 
that aligns with the P4 approach. [20,23,25,26]
In this context, Progress in Preventive Medicine aims to provide 
a platform to publish articles and discuss the principal aspects 
of how healthcare must transform and embody the aforemen-
tioned attributes. Studying complex biological systems in a 
holistic manner as opposed to a “one organ, one gene, or one 
protein” approach requires the concerted effort of scientists 
from a wide variety of disciplines. As such, we are honored that 
many world-leading experts join our endeavor to advance the 
future proactive healthcare system and disseminate knowledge 
through Progress in Preventive Medicine.
Given the rapid and needed evolution of healthcare, there 
could not be a better time for the launch of Progress in Preven-
tive Medicine. This journal will address all topics related to the 
aforementioned areas, from the cellular, to clinical, to the pop-
ulation level. Cutting edge original publications, reviews, case 
reports, and perspectives focusing on healthy lifestyle and preci-
sion medicine will define this journal. Our goal is to rapidly have 
Progress in Preventive Medicine recognized as the premier source 
for information chronicling the transformation of healthcare as 
we all work together to prevent chronic disease, improve qual-
ity of life, and prolong the healthspan. Albert Einstein once said: 
“ Intellectuals solve problems, geniuses prevent them.”—maybe we 
can all aspire to be a bit more like that and look at root causes 
and system interactions to predict and prevent diseases.
It is with great pleasure that we, the leading editors, present 
you with this first edition of the new peer-reviewed open access 
journal Progress in Preventive Medicine. We are grateful to all of 
our colleagues and contributing experts who made this jour-
nal possible and who support this important initiative. We look 
forward to receiving and publishing your articles. Onward and 
upward for health and science, together.
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